Lifecore Biomedical, Inc.
LFCR
$4.54
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 09/30/2025 | 09/30/2025 | 05/25/2025 | |
|---|---|---|---|---|---|
| Net Income | 22.64% | -88.24% | 38.44% | 38.44% | -12.35% |
| Total Depreciation and Amortization | 26.07% | 15.79% | -0.60% | -0.60% | -0.94% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.00% | 8.40% | 49.08% | 49.08% | 17.43% |
| Change in Net Operating Assets | -392.35% | 416.25% | -91.46% | -91.46% | -138.99% |
| Cash from Operations | -166.86% | 43.56% | 374.03% | 374.03% | -62.44% |
| Capital Expenditure | 86.42% | 70.40% | 48.79% | 48.79% | -39.20% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -85.53% | -304.34% | 48.79% | 48.79% | 89.81% |
| Total Debt Issued | -7.43% | 20.34% | 532.18% | 532.18% | -79.35% |
| Total Debt Repaid | 15.78% | -9.49% | -5,192.70% | -5,192.70% | 77.26% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -313.47% | -- | -96.26% | -96.26% | 80.89% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 46.40% | 42.34% | -- | -- | -357.73% |
| Cash from Financing | 76.28% | 92.87% | -226.99% | -226.99% | -485.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -497.31% | 658.99% | 53.67% | 53.67% | -111.04% |